tripitramine has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 3 studies
Studies (tripitramine) | Trials (tripitramine) | Recent Studies (post-2010) (tripitramine) | Studies ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) | Trials ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) | Recent Studies (post-2010) ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) |
---|---|---|---|---|---|
17 | 0 | 0 | 285 | 0 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angeli, P; Cantalamessa, F; Gulini, U; Melchiorre, C | 1 |
Gross, J; Hacksell, U; Hermanni, U; Hildebrandt, C; Hou, X; Lambrecht, G; Moser, U; Nilsson, BM; Pfaff, O; Waelbroeck, M | 1 |
Bolognesi, ML; Budriesi, R; Cacciaguerra, S; Chiarini, A; Melchiorre, C; Minarini, A; Rosini, M; Spampinato, S; Toro, RD; Tumiatti, V | 1 |
3 other study(ies) available for tripitramine and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Article | Year |
---|---|
Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramine.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Benzodiazepines; Blood Pressure; Decerebrate State; Diamines; Heart Rate; Injections, Intravenous; Male; Muscarinic Antagonists; Parasympatholytics; Rats; Receptors, Muscarinic | 1995 |
The design and pharmacology of novel selective muscarinic agonists and antagonists.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Benzodiazepines; Cell Line; Corpus Striatum; Dimethindene; Drug Design; Guinea Pigs; Heart Atria; Intestine, Small; Muscarinic Agonists; Muscarinic Antagonists; Muscle, Smooth; Pancreas; Parasympathomimetics; Pyrrolidines; Rabbits; Rats; Receptors, Muscarinic; Structure-Activity Relationship | 1995 |
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Benzodiazepines; Dose-Response Relationship, Drug; Humans; Male; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Polyamines; Rabbits; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptors, Muscarinic; Vas Deferens | 2001 |